Found: 12
Select item for more details and to access through your institution.
Insulin Tregopil: An Ultra-Fast Oral Recombinant Human Insulin Analog: Preclinical and Clinical Development in Diabetes Mellitus.
- Published in:
- Drugs, 2023, v. 83, n. 13, p. 1161, doi. 10.1007/s40265-023-01925-1
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar insulin N with US‐licensed Humulin® N formulation in healthy subjects: Results from the RHINE‐2 (Recombinant Human INsulin Equivalence‐2) study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1485, doi. 10.1111/dom.14994
- By:
- Publication type:
- Article
Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1589, doi. 10.1111/dom.15007
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin 70/30 with US‐licensed HUMULIN® 70/30 formulation in healthy subjects: Results from the RHINE‐3 (Recombinant Human INsulinEquivalence‐3) study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1819, doi. 10.1111/dom.14768
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin‐R with the US‐licensed Humulin® R formulation in healthy subjects: Results from the RHINE‐1 (Recombinant Human INsulin Equivalence‐1) study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 4, p. 713, doi. 10.1111/dom.14635
- By:
- Publication type:
- Article
Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 365, doi. 10.1111/dom.13904
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 74, doi. 10.1002/cpdd.730
- By:
- Publication type:
- Article
Impact of Insulin Tregopil and Its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open‐Label, Placebo‐Controlled, Crossover Study.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 3, p. 276, doi. 10.1111/cts.12609
- By:
- Publication type:
- Article
Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 129, doi. 10.1111/dom.13495
- By:
- Publication type:
- Article
Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease Not Affected by Co-Administration of Memantine: An Open-Label, Crossover, Single-Centre Study.
- Published in:
- Clinical Drug Investigation, 2008, v. 28, n. 6, p. 361, doi. 10.2165/00044011-200828060-00004
- By:
- Publication type:
- Article
P4-410: Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer’s disease are not affected by co-administration of memantine
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-410: Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer’s disease are not affected by co-administration of memantine
- Published in:
- 2006
- By:
- Publication type:
- Abstract